Literature DB >> 20457141

Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): mechanisms responsible for interindividual variation of UGT levels.

Karl Walter Bock1.   

Abstract

Ten out of 19 UDP-glucuronosyltransferases (UGTs) are substantially expressed in adult human liver (>1% of total UGTs); 5 UGT1 isoforms (UGT1A1, 1A3, 1A4, 1A6 and 1A9) and 5 UGT2 family members (UGT2B4, 2B7, 2B10, 2B15 and 2B17) (Izukawa et al. [11]). Surprisingly, UGT2B4 and UGT2B10 mRNA were found to be abundant in human liver suggesting an underestimated role of the liver in detoxification of their major substrates, bile acids and eicosanoids. Among factors responsible for high interindividual variation of hepatic UGT levels (genetic diversity including polymorphisms and splice variants, regulation by liver-enriched transcription factors such as HNF1 and HNF4, and ligand-activated transcription factors) nuclear receptors (PXR, CAR, PPARalpha, etc.), and the Ah receptor are discussed. Unraveling the mechanisms responsible for interindividual variation of UGT expression will be beneficial for drug therapy but still remains a major challenge. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20457141     DOI: 10.1016/j.bcp.2010.04.034

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  32 in total

Review 1.  First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.

Authors:  Baojian Wu; Kaustubh Kulkarni; Sumit Basu; Shuxing Zhang; Ming Hu
Journal:  J Pharm Sci       Date:  2011-04-11       Impact factor: 3.534

2.  Hepatic expression of transcription factors affecting developmental regulation of UGT1A1 in the Han Chinese population.

Authors:  Ya-Li Nie; Hang He; Jiang-Feng Li; Xiang-Guang Meng; Liang Yan; Pei Wang; Shu-Jie Wang; Hong-Zheng Bi; Li-Rong Zhang; Quan-Cheng Kan
Journal:  Eur J Clin Pharmacol       Date:  2016-10-05       Impact factor: 2.953

3.  Quantification of the impact of enzyme-inducing antiepileptic drugs on irinotecan pharmacokinetics and SN-38 exposure.

Authors:  Alexander K Berg; Jan C Buckner; Evanthia Galanis; Kurt A Jaeckle; Matthew M Ames; Joel M Reid
Journal:  J Clin Pharmacol       Date:  2015-06-26       Impact factor: 3.126

4.  Regulation of hepatic phase II metabolism in pregnant mice.

Authors:  Xia Wen; Ajay C Donepudi; Paul E Thomas; Angela L Slitt; Roberta S King; Lauren M Aleksunes
Journal:  J Pharmacol Exp Ther       Date:  2012-10-10       Impact factor: 4.030

Review 5.  Drug metabolism alterations in nonalcoholic fatty liver disease.

Authors:  Matthew D Merrell; Nathan J Cherrington
Journal:  Drug Metab Rev       Date:  2011-05-25       Impact factor: 4.518

6.  An efficient method for differentiation of human induced pluripotent stem cells into hepatocyte-like cells retaining drug metabolizing activity.

Authors:  Yuki Kondo; Takahiro Iwao; Katsunori Nakamura; Takamitsu Sasaki; Shogo Takahashi; Noboru Kamada; Tsutomu Matsubara; Frank J Gonzalez; Hidenori Akutsu; Yoshitaka Miyagawa; Hajime Okita; Nobutaka Kiyokawa; Masashi Toyoda; Akihiro Umezawa; Kiyoshi Nagata; Tamihide Matsunaga; Shigeru Ohmori
Journal:  Drug Metab Pharmacokinet       Date:  2013-12-10       Impact factor: 3.614

7.  Interethnic differences in UGT1A4 genetic polymorphisms between Mexican Mestizo and Spanish populations.

Authors:  Marisol López; Pedro Dorado; Alberto Ortega; Eva Peñas-Lledó; Nancy Monroy; Irma Silva-Zolezzi; Jesús Cobaleda; Alicia Gallego-Aguilera; María Elisa Alonso; Adrián Llerena
Journal:  Mol Biol Rep       Date:  2013-01-01       Impact factor: 2.316

8.  RNA-sequencing quantification of hepatic ontogeny and tissue distribution of mRNAs of phase II enzymes in mice.

Authors:  Hong Lu; Sumedha Gunewardena; Julia Y Cui; Byunggil Yoo; Xiao-bo Zhong; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2013-02-04       Impact factor: 3.922

9.  Importance of detoxifying enzymes in differentiating fibrotic development between SHRSP5/Dmcr and SHRSP rats.

Authors:  Hisao Naito; Xiaofang Jia; Husna Yetti; Yukie Yanagiba; Hazuki Tamada; Kazuya Kitamori; Yumi Hayashi; Dong Wang; Masashi Kato; Akira Ishii; Tamie Nakajima
Journal:  Environ Health Prev Med       Date:  2016-05-21       Impact factor: 3.674

10.  4-Methylumbelliferone Diminishes Catabolically Activated Articular Chondrocytes and Cartilage Explants via a Mechanism Independent of Hyaluronan Inhibition.

Authors:  Shinya Ishizuka; Emily B Askew; Naoko Ishizuka; Cheryl B Knudson; Warren Knudson
Journal:  J Biol Chem       Date:  2016-04-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.